Document Detail


Acute respiratory distress syndrome in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial trifunctional protein deficiencies.
MedLine Citation:
PMID:  14605499     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Inborn errors of metabolism have not previously been recognized as a risk factor for acute respiratory distress syndrome (ARDS). We report this complication in four patients with defects of the mitochondrial trifunctional protein (MTP). This enzyme catalyses three steps in the beta-oxidation of long-chain fatty acids. Three of the patients were homozygous for the 'common' 1528G>C mutation in the alpha-subunit of the MTP, giving rise to long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. The fourth patient did not carry this mutation but had severely decreased activities of long-chain 3-hydroxyacyl-CoA dehydrogenase and long-chain 3-ketoacyl-CoA thiolase. One patient died and histology in this patient showed severe interstitial pulmonary fibrosis. The other three patients recovered after being ventilated for up to 6 months. The high frequency of ARDS in patients with MTP defects suggests that this inborn error may be a risk factor for ARDS.
Authors:
C T Lundy; J P H Shield; E A Kvittingen; O J Vinorum; E R Trimble; A A M Morris
Related Documents :
3180649 - Relapsing polychondritis.
11460959 - Tetanus in adults: a review of 85 cases at chon buri hospital.
2107999 - Use of capnography in diagnosis of pulmonary embolism during acute respiratory failure ...
1813589 - Chronic obstructive pulmonary disease at chulalongkorn hospital: an analysis of 400 epi...
3619169 - Intravenous use of glycopyrrolate in acute respiratory distress due to bronchospastic p...
8180909 - Newborn apnea caused by a neurofibroma at the craniocervical junction.
17710489 - Intravenous pantoprazole utilization in a level 1 trauma center.
24466449 - Prevalence of extraesophageal symptoms in patients with gastroesophageal reflux disease...
21323689 - Review article: remission rates achievable by current therapies for inflammatory bowel ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of inherited metabolic disease     Volume:  26     ISSN:  0141-8955     ISO Abbreviation:  J. Inherit. Metab. Dis.     Publication Date:  2003  
Date Detail:
Created Date:  2003-11-10     Completed Date:  2004-06-17     Revised Date:  2012-11-16    
Medline Journal Info:
Nlm Unique ID:  7910918     Medline TA:  J Inherit Metab Dis     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  537-41     Citation Subset:  IM    
Affiliation:
Departments of Child Health and Clinical Biochemistry, Royal Belfast Hospitalfor Sick Children, Belfast.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3-Hydroxyacyl CoA Dehydrogenases / deficiency*,  genetics
Anti-Inflammatory Agents / therapeutic use
Female
HELLP Syndrome / complications
Humans
Infant
Infant, Newborn
Lipid Metabolism, Inborn Errors / complications*,  diet therapy
Lung / pathology
Male
Methylprednisolone / therapeutic use
Multienzyme Complexes / deficiency*,  genetics
Pregnancy
Respiratory Distress Syndrome, Newborn / etiology*,  pathology
Respiratory Function Tests
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Multienzyme Complexes; 0/mitochondrial fatty acid beta-oxidation trifunctional protein; 83-43-2/Methylprednisolone; EC 1.1.1.211/long-chain 3-hydroxyacyl CoA dehydrogenase; EC 1.1.1.35/3-Hydroxyacyl CoA Dehydrogenases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reversible posterior leukoencephalopathy syndrome in a child with cerebral X-linked adrenoleukodystr...
Next Document:  Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency.